Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Multiple SPF Categories Will "Confuse" Consumers - Skin Cancer Foundation

This article was originally published in The Tan Sheet

Executive Summary

FDA's tri-level SPF categories in the final sunscreen monograph "will confuse consumers and limit their ability to obtain adequate sun protection," the Skin Cancer Foundation states in June 3 comments to the agency.

You may also be interested in...

FDA May Reconsider SPF 30+ Sunscreen Labeling Requirement

FDA may be willing to reconsider the sunscreen final monograph requirement that sunscreen products with SPFs over 30 may only state they are "30 plus," Office of Drug Evaluation V Director Robert DeLap, MD/PhD, said at an OTC "feedback" meeting on the reg in Rockville, Md. July 22. "We haven't closed any doors in a permanent sense" regarding the provision, DeLap told attendees.

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts